Predict your next investment

Venture Capital
biomedicine.ch

See what CB Insights has to offer

Investments

2

Portfolio Exits

1

Funds

1

About Biomedicine

International BM Biomedicine Holdings is an investment firm which invests in leading technology-based, research-oriented biotechnology companies in the pharmaceutical area. The firm uses Global Biomedical Partners as its exclusive investment advisor to perform due diligence and make recommendations that IBMH acts on.

Biomedicine Headquarter Location

Nauenstrasse 41

Basel, 4002,

Switzerland

41 61 270 8210

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Biomedicine Investments

2 Investments

Biomedicine has made 2 investments. Their latest investment was in Artemis Pharmaceuticals as part of their Series B on April 4, 2000.

CBI Logo

Biomedicine Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/5/2000

Series B

Artemis Pharmaceuticals

$12.56M

No

3i Group, Advent International, Atlas Venture, Global Life Science Ventures, Oxford Bioscience Partners, Sal. Oppenheim Private Equity Partners, and Undisclosed Investors

1

9/16/1998

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/5/2000

9/16/1998

Round

Series B

Series A

Company

Artemis Pharmaceuticals

Subscribe to see more

Amount

$12.56M

$99M

New?

No

Subscribe to see more

Co-Investors

3i Group, Advent International, Atlas Venture, Global Life Science Ventures, Oxford Bioscience Partners, Sal. Oppenheim Private Equity Partners, and Undisclosed Investors

Sources

1

10

Biomedicine Portfolio Exits

1 Portfolio Exit

Biomedicine has 1 portfolio exit. Their latest portfolio exit was Artemis Pharmaceuticals on April 01, 2001.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/1/2001

Acquired

Undisclosed Investors

1

Date

4/1/2001

Exit

Acquired

Companies

Valuation

Acquirer

Undisclosed Investors

Sources

1

Biomedicine Fund History

1 Fund History

Biomedicine has 1 fund, including Biomedicine LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

1/1/2000

Biomedicine LP

Buyouts & Acquisitions

$73.53M

1

Closing Date

1/1/2000

Fund

Biomedicine LP

Fund Type

Buyouts & Acquisitions

Status

Amount

$73.53M

Sources

1

Biomedicine Team

4 Team Members

Biomedicine has 4 team members, including current Chief Executive Officer, Patrick Weber.

Name

Work History

Title

Status

Patrick Weber

Chief Executive Officer

Current

Richard J Dold

Chief Executive Officer

Former

Stefan Ryser

Chief Executive Officer

Former

Michael E Meyers

Managing Partner

Former

Name

Patrick Weber

Richard J Dold

Stefan Ryser

Michael E Meyers

Work History

Title

Chief Executive Officer

Chief Executive Officer

Chief Executive Officer

Managing Partner

Status

Current

Former

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.